4//SEC Filing
ANDREWS DEBORAH J 4
Accession 0001493152-21-015788
CIK 0000876343other
Filed
Jun 29, 8:00 PM ET
Accepted
Jun 30, 7:01 PM ET
Size
19.8 KB
Accession
0001493152-21-015788
Insider Transaction Report
Form 4
ANDREWS DEBORAH J
Director
Transactions
- Sale
Common Shares, no par value
2021-06-29$2.93/sh−19,142$56,086→ 15,578 total - Exercise/Conversion
Common Shares, no par value
2021-06-29$2.20/sh+24,720$54,384→ 34,720 total - Exercise/Conversion
Stock Option (right to buy)
2021-06-29−24,720→ 0 totalExercise: $2.20Exp: 2021-06-30→ Common Shares (24,720 underlying)
Footnotes (2)
- [F1]The price reported is a weighted average. These shares were sold in multiple transactions at a price of $2.93 or $2.935. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
- [F2]This option became exercisable in four equal quarterly installments after the date of grant on July 1, 2016
Documents
Issuer
Lineage Cell Therapeutics, Inc.
CIK 0000876343
Entity typeother
Related Parties
1- filerCIK 0001325697
Filing Metadata
- Form type
- 4
- Filed
- Jun 29, 8:00 PM ET
- Accepted
- Jun 30, 7:01 PM ET
- Size
- 19.8 KB